Yu Chao Selected Research

Yu Chao Research Topics

Disease

48	Neoplasms (Cancer) 01/2023 - 01/2016
12	Hypoxia (Hypoxemia) 01/2019 - 08/2014
7	Neoplasm Metastasis (Metastasis) 12/2020 - 10/2017
4	Melanoma (Melanoma, Malignant) 01/2024 - 01/2019
3	Breast Neoplasms (Breast Cancer) 12/2020 - 10/2013
2	Hyperthermia 10/2019 - 10/2017
2	Osteosarcoma (Osteogenic Sarcoma) 06/2019 - 01/2019
1	Non-alcoholic Fatty Liver Disease 04/2024
1	Inflammation (Inflammations) 03/2024
1	Colitis 03/2024
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Choroidal Neovascularization 01/2023
1	Eye Diseases (Eye Disease) 01/2023
1	Alcoholism (Alcohol Abuse) 12/2022
1	Bites and Stings (Sting) 08/2022
1	Glioma (Gliomas) 01/2022
1	Non-Muscle Invasive Bladder Neoplasms 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Fibrosis (Cirrhosis) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Ureteral Obstruction 01/2021

Drug/Important Bio-Agent (IBA)

9	Radioisotopes (Radionuclides)IBA 01/2019 - 01/2016
8	Oxygen (Dioxygen)IBA 11/2018 - 04/2016
6	Immune Checkpoint InhibitorsIBA 01/2024 - 10/2019
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2018 - 04/2016
5	Photosensitizing Agents (Photosensitizers)IBA 11/2018 - 01/2017
5	PolymersIBA 09/2018 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2018
4	HydrogelsIBA 01/2023 - 01/2018
4	Therapeutic UsesIBA 01/2019 - 10/2017
4	Liposomes (Liposome)IBA 01/2019 - 01/2017
4	Chelating AgentsIBA 11/2018 - 01/2017
4	CatalaseIBA 11/2018 - 09/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 11/2018
3	AntibodiesIBA 01/2024 - 01/2022
3	Cancer VaccinesIBA 11/2021 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 08/2017
3	NanovaccinesIBA 11/2021 - 01/2019
3	MicroRNAs (MicroRNA)IBA 01/2020 - 12/2018
3	phytochlorinIBA 01/2018 - 04/2016
2	ChitosanIBA 01/2024 - 01/2022
2	CopperIBA 12/2022 - 01/2018
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022 - 01/2017
2	PlatinumIBA 01/2022 - 01/2022
2	CPG-oligonucleotideIBA 11/2021 - 01/2018
2	AntigensIBA 01/2019 - 10/2013
2	EnzymesIBA 10/2018 - 09/2017
2	AlbuminsIBA 08/2018 - 10/2017
2	vanadium disulfideIBA 07/2018 - 10/2017
2	Singlet OxygenIBA 01/2018 - 11/2017
2	manganese dioxideIBA 10/2017 - 01/2017
2	Oxidoreductases (Dehydrogenase)IBA 01/2015 - 08/2014
1	Biomarkers (Surrogate Marker)IBA 04/2024
1	rheinIBA 03/2024
1	CarbonIBA 03/2024
1	Viral VaccinesIBA 01/2024
1	FluorocarbonsIBA 01/2024
1	Biocompatible Materials (Biomaterials)IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	atezolizumabIBA 01/2023
1	CTLA-4 AntigenIBA 01/2023
1	Ophthalmic Solutions (Eye Drops)IBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	calcium phosphateIBA 12/2022
1	IonsIBA 12/2022
1	Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link 12/2022
1	Disulfiram (Antabuse)FDA Link 12/2022
1	InterferonsIBA 08/2022
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 08/2022
1	Glutaral (Glutaraldehyde)IBA 01/2022
1	HydrogenIBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	MagnesiumIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	AldehydesIBA 01/2022
1	AminesIBA 01/2022
1	CollagenIBA 01/2022
1	VaccinesIBA 11/2021
1	Cell Adhesion MoleculesIBA 11/2021
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 11/2021
1	Toll-Like Receptor 9IBA 11/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	nintedanibIBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021

Therapy/Procedure

27	Therapeutics 03/2024 - 01/2016
14	Intravenous Injections 01/2024 - 02/2016
12	Immunotherapy 01/2024 - 10/2018
10	Radiotherapy 01/2019 - 01/2017
10	Precision Medicine 10/2018 - 01/2016
8	Photochemotherapy (Photodynamic Therapy) 11/2018 - 04/2016
6	Drug Therapy (Chemotherapy) 01/2020 - 12/2016
5	Photothermal Therapy 01/2020 - 02/2016
3	Lasers (Laser) 01/2020 - 02/2016
1	Injections 03/2024
1	Intravitreal Injections 01/2023
1	Immunomodulation 01/2022
1	Intravesical Administration 01/2022